Why did a US court block Trump’s tariffs?
How will Tesla’s robotaxi launch impact ride-hailing?
What caused Victoria's Secret website shutdown?
How are tariffs affecting US tech companies?
Why is Nvidia's stock rising despite China export bans?
What’s behind e.l.f. Beauty’s $1 billion acquisition?
How did JetBlue-United loyalty alliance change airline travel?
These Analysts Slash Their Forecasts On Rocket Pharmaceuticals
benzinga.com/25/05/45641790/these-analysts-slash-their-forecasts-on-rocket-pharmaceuticals
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced an update Tuesday related to RP-A501, its investigational gene therapy for Danon disease, a rare X-linked dominant genetic disorder that manifests with the clinical triad of cardiomyopathy (stiff heart muscles), skeletal myopathy…
This story appeared on benzinga.com, 2025-05-28 12:22:19.